Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-15 · accession 0001209191-21-070257 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-17 | 2021-12-15 | AMRX | Shah Nikita | EVP | S - Sale | $3.95 | -2,000 | 213.0K | -0.9% | -$7,900 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-12-15 | S | D | 2,000 | $3.95 | 212,996 | D | — | — |